Making our vaccines more accessible
Home
Our news
ViiV Healthcare announces phase II study results for first two drug, long-acting injectable regimen for HIV-1 treatment
Four inspiring innovations which help reduce child deaths in developing countries share $1 million prize from GSK and Save the Children
GSK’s global HIV business ViiV Healthcare completes transactions to acquire Bristol-Myers Squibb’s R&D HIV assets
Corporate reporting
Join the conversation
Tweets from GSK
-
Child PIP - a #healthcareinnovation used by healthcare teams in half of public hospitals in S Africa’s 9 provinces https://t.co/uVuji8YFDC
12 hours ago
-
From onesies to birth companions, @2020microclinic ‘Operation Karibu’ is helping new mums access healthcare https://t.co/GIkq9rScrp
12 hours ago
Explore our products
We make a wide range of prescription medicines, prescribed vaccines and consumer healthcare products.
